tiprankstipranks
HealthCare Global Enterprises Ltd. (IN:HCG)
:HCG
India Market
HCG
HealthCare Global Enterprises Ltd.
RESEARCH TOOLSreports
Holding IN:HCG?
Track your performance easily

HealthCare Global Enterprises Ltd. (HCG) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

HCG Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
HealthCare
Global Enterprises Ltd.
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HCG Stock 12 Month Forecast

There Are No Analyst Ratings for IN:HCG In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

HCG Financial Forecast

HCG Earnings Forecast

Next quarter’s earnings estimate for HCG is ₹0.55 with a range of ₹0.55 to ₹0.55. The previous quarter’s EPS was ₹1.30. HCG beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.00% of the time in the same period. In the last calendar year HCG has Preformed in-line its overall industry.
Next quarter’s earnings estimate for HCG is ₹0.55 with a range of ₹0.55 to ₹0.55. The previous quarter’s EPS was ₹1.30. HCG beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 54.00% of the time in the same period. In the last calendar year HCG has Preformed in-line its overall industry.

HCG Sales Forecast

Next quarter’s sales forecast for HCG is ₹5.71B with a range of ₹5.41B to ₹6.30B. The previous quarter’s sales results were ₹5.52B. HCG beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 44.44% of the time in the same period. In the last calendar year HCG has Outperformed its overall industry.
Next quarter’s sales forecast for HCG is ₹5.71B with a range of ₹5.41B to ₹6.30B. The previous quarter’s sales results were ₹5.52B. HCG beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 44.44% of the time in the same period. In the last calendar year HCG has Outperformed its overall industry.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

HCG Analyst Recommendation Trends

Currently, no data available
Please return soon. This page is being updated.
Each month's total comprises the sum of three months' worth of ratings.

HCG Stock Forecast FAQ

What is IN:HCG’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:HCG’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:HCG, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is HealthCare Global Enterprises Ltd. a Buy, Sell or Hold?
      Currently, no data Available
      What is HealthCare Global Enterprises Ltd.’s share price target?
      Currently, no data Available
      What do analysts say about HealthCare Global Enterprises Ltd.?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of HealthCare Global Enterprises Ltd.?
      To buy shares of IN:HCG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis